Woman looking up and to the side on a geometric background.
Frequently Asked Questions About Opill® and Contraception Access

Stopping Opill®

What if I want to become pregnant while taking Opill®?

If you decide you want to become pregnant, simply stop taking Opill®. Opill® will not delay your ability to get pregnant once you choose to stop taking it.

What happens if I want to stop taking Opill® birth control?

You can stop taking Opill® at any time without finishing the pack. Once you stop taking Opill®, you are no longer protected against pregnancy. If you do not want to get pregnant, you should use another birth control method.

What will happen to my period if I stop taking Opill®?

If you stop taking Opill®, your bleeding pattern should return to what it was before taking Opill®, which can take as little as one cycle. If you stop taking Opill®, your ability to get pregnant will not be delayed.

Are there any side effects to stopping progestin-only pills (POPs) like Opill®?

When you stop taking progestin-only pills (POPs) like Opill®, you are no longer protected from pregnancy. Your hormone levels will return to normal, you will start ovulating again, and your cervical mucus will change so that it’s easier for sperm to reach the egg if you have unprotected sex. If you experienced changes to your period, it may take a few cycles for them to return to your normal. Talk to your doctor if you have concerns about side effects after stopping POPs.

Can you take breaks from taking Opill®?

Opill® should be taken every day within the same 3-hour timeframe for maximum efficacy.

You can stop using Opill® at any time without finishing the pack. Once you stop taking Opill® you are no longer protected from pregnancy so if you still do not want to get pregnant, you should use another birth control method.

When you are ready to start taking Opill® again, you can begin on any day of your cycle. Remember, Opill® starts working 48 hours after you take your first pill so be sure to use a condom for the first two days to prevent pregnancy. Read all the label information and use Opill® as directed.

How do you cancel an Opill® order?

To cancel an Opill® order, log in to your account and navigate to ‘Subscriptions’ in the main menu to cancel, manage, or make changes. For additional support, please contact our customer service team at support.opill.com.

More information by topic




References

[1] U.S. Food and Drug Administration. (2023, July 14). Opill (0.075mg Oral Norgestrel Tablet) Information. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-andproviders/opill-0075mg-oral-norgestrel-tablet-information

[2] Worly BL, Gur TL, Schaffir J. The relationship between progestin hormonal contraception and depression: a systematic review. Contraception. 2018 Jun;97(6):478-489. doi: 10.1016/j.contraception.2018.01.010. Epub 2018 Feb 26. PMID: 29496297.

[3] Lee IT, Barnhart KT. What Is an Ectopic Pregnancy? JAMA. 2023;329(5):434. doi:10.1001/jama.2022.22941

[4] Planned Parenthood. What is ectopic pregnancy?: Definition and treatment. Ectopic Pregnancy.Retrieved November 17, 2023, from https://www.plannedparenthood.org/learn/pregnancy/ectopic-pregnancy.

[5] Lopez LM, Ramesh S, Chen M, Edelman A, Otterness C, Trussell J, Helmerhorst FM. Progestin-only contraceptives: effects on weight. Cochrane Database Syst Rev. 2016 Aug 28;2016(8):CD008815. doi:10.1002/14651858.CD008815.pub4. PMID: 27567593; PMCID: PMC5034734.

[6] Graham CA, Ramos R, Bancroft J, Maglaya C, Farley TM. The effects of steroidal contraceptives on the well-being and sexuality of women: a double-blind, placebo-controlled, two-centre study of combined and progestogen-only methods. Contraception. 1995 Dec;52(6):363-9. doi:10.1016/0010-7824(95)00226-x. PMID: 8749600.

[7] Curtis KM et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2016. MMWR Recomm Rep 2016;65(No. RR-3):1–104. DOI: http://dx.doi.org/10.15585/mmwr.rr6503a1Curtis KM et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2016. MMWR Recomm Rep 2016;65(No. RR-3):1–104. doi:http://dx.doi.org/10.15585/mmwr.rr6503a1-8-